Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients

NCT04397653 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hypercholesterolemia
Chronic Kidney Disease Requiring Chronic Dialysis

Interventions

DRUG: Evolocumab
DRUG: Placebo
DRUG: Ezetimibe

Sponsor

Policlinico Casilino ASL RMB

Collaborators

[object Object]